Weichteilsarkom: Studien
Pembrolizumab, radiation therapy,and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity
Randomisierte Phase II-Studie zum Einsatz von liposomalem Doxorubicin (Myocet) plus Ifosfamid versus Doxorubicin plus Ifosfamid in der Primärtherapie des lokal fortgeschrittenen oder metastasierten Weichteilsarkoms
Testung des mTOR-Inhibitor Ridaforolimus
Testung eines VEGF-Rezeptor-IH
„SAREZ- SArkom REZidivregister Sarcoma Relapse Registry for relapsed sarcoma of bone and soft tissues“
Doxorubicin alone versus doxorubicin plus ifosfamide for first line treatment of advanced or metastatic soft-tissue sarcoma.
Bei high-risk Weichteilsarkomen im Erwachsenenalter verbessert eine Hyperthermie das Ergebnis einer präoperativen EIC-Chemotherapie.
Preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcomas
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume
Trabectedin or cacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy.
